encorafenib,cetuximab
eli lilly,pfizer,merck
['encorafenib', 'crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'triplet', 'cetuximab', 'aura ']
#asco22 a summary of june 3 crc session on precision medicine in crc braf mss/pmmr braf v600e crc triplet combinations show promise clinical trial with encorafenib/cetuximab with chemo up front may shed light 
Independent Medical Affairs Advisor & Research/Patient Advocate. metastatic colon cancer survivor diagnosed 2003 NED since 2006.
FCOI: https://t.co/cRjnIJrYKm